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Carbapenem-hydrolyzing ß-lactamases are the most powerful
-lactamases being able to hydrolyse almost all ß-lactams. They
re mostly of the KPC, VIM, IMP, NDM and OXA-48 type in Enter-
bacteriaceae. Detection of infected patients relies on detection of
arbapenemase producers from infected sites. Rapid biochemical
dentiﬁcation of carbapenemase producers (NP Rapid Carba test)
s now available and subsequent molecular-based techniques may
dentify the molecular type of carbapenemase genes. Detection of
arriers is made ﬁrst by using screening culture media such as the
upercarba medium which is the latest developped.
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Carbapenem resistance in Acinetobacter baumannii and Enter-
bacteriaceae ranks as one of the most serious and challenging
ublic health problem worldwide. Antibiotic treatment option is
xtremely limited and antibiotic development pipeline for gram-
egative bacteria is unpromising. While KPC beta-lactamases are
urrently reported in North America and Europe, and limited coun-nfectious Diseases 16S (2012) e2–e157 e27
tries in the Far East, OXA carbapenemases in A. baumannii and New
Delhimetallo-beta-lactamase (NDM-1) in Enterobacteriaceae have
disseminated globally. Control measures for multidrug-resistant
(MDR) organisms comprise a combination of infection control and
antimicrobial stewardship program (ASP). Horizontal transmis-
sion of gram-negative bacteria with the exception of A. baumannii
is less recognized until recently. Antibiotic selection pressure is
thought to be more important in the emergence of MDR gram-
negative bacteria. ASP has been successful in containing outbreak
of extended-spectrum beta-lactamase producing Enterobacteri-
aceae and MDR Pseudomonas aeruginosa. Reduction in antibiotic
resistance ingram-negativebacteriahasbeenobservedwith reduc-
tion in use of broad-spectrum antibiotics. Experience with ASP in
containing MDR A.baumannii and KPC Enterobacteriaceae will be
reviewed. The results of 3 years of a comprehensive multi-faceted
multi-disciplinary ASP at Tan Tock Seng Hospital in Singapore will
be shared, where reduction in carbapenem use was associated
with sustained reduction in carbapenem-resistant P. aeruginosabut
not MDR A. baumannii. Rebound in carbapenem overuse has been
associated with emergence of carbapenem-resistant Enterobacte-
riaceae including locally acquired NDM-1.
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The role of infection control in curbing Carbapenem resistance
A. Apisarnthanarak
Thammasat University Hospital, Pratumthani, Thailand
Carbapenem resistant Gram-negative pathogens have become a
threat to many countries in Western Paciﬁc Region. These microor-
ganisms are difﬁcult to treat and pose challenges for control
strategies. Much of the emergence and spread of carbapenem
resistant Gram-negative pathogens can be contributed to the non-
judicious use of broad-spectrum antibiotics and poor infection
control.Onceantimicrobial resistanceemerges, it canhavea signiﬁ-
cant impact onpatientmorbidity andmortality, aswell as increased
health care costs.
Antimicrobial stewardship is a key component of a multi-
faceted approach to preventing the emergence of carbapenem
resistant Gram-negative pathogens. Application of antimicrobial
stewardship to resource-limited setting can be challenging. The
antimicrobial stewardship program at Thammasat University Hos-
pital, which has been associated with appropriateness of antibiotic
use and improved treatment rates, decreased failure rates, and
reduced healthcare-related costs, is an example of this mul-
tifaceted, multidisciplinary approach. The components of our
antimicrobial stewardship program include continuous education,
introduction of the antibiogram, antibiotic guideline, and antibi-
otic prescription forms with an antimicrobial stewardship team
to continuously monitor the consumption of and audit the use
of antibiotics with real-time, bed-side discussion with prescribing
physicians. This antimicrobial stewardship program began in 2004
and appears to have been sustained over a 8-year period. Never-
theless, to sustain or even further improve these results, lasting
and repeated efforts will be needed. Integrating infection control
efforts into educational and antimicrobial stewardship programs
